The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm800962kPMID 19146417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent Advances in the Pharmacological Management of Pain

  2012cited by this paper
• The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.

  2008cited by this paper
• Spinal glial activation contributes to pathological pain states.

  2008cited by this paper
• Intrathecal analgesia for refractory cancer pain

  2008cited by this paper
• NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats

  2008cited by this paper
• Anger inhibition and pain: conceptualizations, evidence and new directions

  2008cited by this paper
• Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22.

  2008cited by this paper
• Pronociceptive actions of dynorphin via bradykinin receptors.

  2008cited by this paper
• Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.

  2007cited by this paper
• Kv7 (KCNQ) channel modulators and neuropathic pain.

  2007cited by this paper
• Sensory neuron-specific receptor agonist BAM8-22 inhibits the development and expression of tolerance to morphine in rats.

  2007cited by this paper
• Current and emerging targets to treat neuropathic pain.

  2007cited by this paper
• Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain.

  2007cited by this paper
• The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.

  2007cited by this paper
• Neuropathic pain: molecular complexity underlies continuing unmet medical need.

  2007cited by this paper
• Sodium channel blockers.

  2007cited by this paper
• N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief.

  2007cited by this paper
• Characterization of the Mas‐related gene family: structural and functional conservation of human and rhesus MrgX receptors

  2006cited by this paper
• Identification of small molecule antagonists of the human mas-related gene-X1 receptor.

  2006cited by this paper
• Molecular mechanism of 7TM receptor activation--a global toggle switch model.

  2006cited by this paper
• Effects of Glycogen Synthase Kinase 3β and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats

  2006cited by this paper
• Adaptive evolution of MRGX2, a human sensory neuron specific gene involved in nociception.

  2005cited by this paper
• Cloning and expression of MRG receptors in macaque, mouse, and human.

  2005cited by this paper
• Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI).

  2005cited by this paper
• Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats.

  2004cited by this paper
• Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family

  2003cited by this paper
• Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs

  2002cited by this paper
• Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors.

  2002cited by this paper
• A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons.

  2001cited by this paper
• QXP: Powerful, rapid computer algorithms for structure-based drug design

  1997cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Reversal of Morphine Tolerance after Medial Thalamic Lesions in the Rat

  1974cited by this paper

• Study on the protective mechanism of neuropeptide S in neonates with hypoxic ischemic encephalopathy

  2023cites this paper
• Thieno[2,3-d]pyrimidine-Based Positive Allosteric Modulators of Human Mas-Related G Protein-Coupled Receptor X1 (MRGPRX1).

  2022cites this paper
• Mas-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs.

  2022cites this paper
• Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.

  2019cites this paper
• Divergent Reactivity of N-Isocyanates with Primary and Secondary Amines: Access to Pyridazinones and Triazinones.

  2016cites this paper
• Effects of the mas-related gene (Mrg) C receptor agonist BAM6-22 on nociceptive reflex activity in naive, monoarthritic and mononeuropathic rats after intraplantar and intrathecal administration.

  2016cites this paper
• Discovery and Characterization of 2‐(Cyclopropanesulfonamido)‐N‐(2‐ethoxyphenyl)benzamide, ML382: a Potent and Selective Positive Allosteric Modulator of MrgX1

  2015cites this paper
• Peptidomimetics of Arg-Phe-NH2 as small molecule agonists of Mas-related gene C (MrgC) receptors.

  2014cites this paper
• Expression and distribution patterns of Mas-related gene receptor subtypes A–H in the mouse intestine: inflammation-induced changes

  2013cites this paper
• Synthesis of biologically active bridged diazabicycloheptanes.

  2012cites this paper
• The effect of inflammation on the expression and distribution of the MAS-related gene receptors MrgE and MrgF in the murine ileum

  2011cites this paper
• GPCR Homology Model Development and Application

  2010cites this paper
• Knowledge-based analysis of multi-potent G-protein coupled receptors ligands.

  2010cites this paper
• Functional molecules from natural sources: Organized by the Royal Society of Chemistry Biotechnology Group, Magdalen College, Oxford, UK, 6–8 July 2009

  2009cites this paper